182 related articles for article (PubMed ID: 12878174)
1. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors.
Ye X; Liang M; Meng X; Ren X; Chen H; Li ZY; Ni S; Lieber A; Hu F
Biochem Biophys Res Commun; 2003 Aug; 307(4):759-64. PubMed ID: 12878174
[TBL] [Abstract][Full Text] [Related]
2. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
3. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
5. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
Steinwaerder DS; Lieber A
Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
[TBL] [Abstract][Full Text] [Related]
6. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
7. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
[TBL] [Abstract][Full Text] [Related]
8. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
[TBL] [Abstract][Full Text] [Related]
9. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
10. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
11. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N
Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
14. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
15. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Pin RH; Reinblatt M; Fong Y
Ann Surg; 2004 Oct; 240(4):659-65; discussion 665-6. PubMed ID: 15383793
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
17. [Adenovirus mediated targeted genetherapy of Staphylococcal enterotoxin A and CD80 for hepatoma and its primary immune mechanisms].
Si SY; Hu PZ; Huang Y; Li X; Ge W; Zhang XM; Sui YF; Zhang JZ; Zhang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):278-81. PubMed ID: 18328193
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].
Li DM; Li W; Tao M; Chen K; Gong FR; Xu ZK; Chen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):459-63. PubMed ID: 24034849
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
